GENETIC SIGNATURES LIMITED - News & Media

Market Cap $155.4M Add to my watchlist

Genetic Signatures Limited is an Australia-based specialist molecular diagnostics (MDx)... Genetic Signatures Limited is an Australia-based specialist molecular diagnostics (MDx) company. The Company's principal activities include research and commercialization of identifying individual genetic signatures to identify diseases and the sale of associated products into the diagnostic and research marketplaces. The Company is focused on the development and commercialization of its platform technology, 3base. Its MDx 3base platform technology provides high-volume hospitals and pathology laboratories with the ability to screen for an array of infectious pathogens, with a high degree of specificity, in a rapid throughput (time-to-result) environment. It designs and manufactures a suite of real-time Polymerase Chain Reaction (PCR) based products for the routine detection of infectious diseases under the EasyScreen brand. Its products include EasyScreen Pan-Enteric Detection Kit, EasyScreen STI Genital Pathogen Detection, EasyScreen Viral Meningitis Detection Kit, and others. More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

No News & Media currently available.

(20min delay)
Last 69.0¢		Change -0.025(3.50%)		Mkt cap ! $155.4M

Open	High	Low	Value	Volume
68.5¢	69.0¢	68.5¢	$13.72K	20.03K

Buyers (Bids)

No.	Vol.	Price($)
1	8524	69.0¢

Sellers (Offers)

Price($)	Vol.	No.
71.5¢	3598	2

View Market Depth

No.	Vol.	Price($)
1	15000	0.710
2	10880	0.680
1	100000	0.650
1	1627	0.615
0	0	0.000

Price($)	Vol.	No.
0.740	15725	2
0.750	22017	2
0.760	39008	2
0.800	500	1
0.810	40999	1

Last trade - 15.44pm 15/11/2024 (20 minute delay)

GSS (ASX) Chart